These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32444701)

  • 1. The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.
    James NE; Emerson JB; Borgstadt AD; Beffa L; Oliver MT; Hovanesian V; Urh A; Singh RK; Rowswell-Turner R; DiSilvestro PA; Ou J; Moore RG; Ribeiro JR
    Sci Rep; 2020 May; 10(1):8558. PubMed ID: 32444701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.
    Rowswell-Turner RB; Singh RK; Urh A; Yano N; Kim KK; Khazan N; Pandita R; Sivagnanalingam U; Hovanesian V; James NE; Ribeiro JR; Kadambi S; Linehan DC; Moore RG
    J Immunol; 2021 May; 206(10):2478-2488. PubMed ID: 33903172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.
    James NE; Gura M; Woodman M; Freiman RN; Ribeiro JR
    Med Oncol; 2022 May; 39(5):71. PubMed ID: 35568777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
    Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
    Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer and normal fallopian tube high WFDC2 expression does not correlate with HE4 serum level.
    Gąsiorowska E; Walkowiak GP; Warchoł W; Lemańska A; Jankowska A; Nowak-Markwitz E
    Ginekol Pol; 2015 May; 86(5):335-9. PubMed ID: 26117969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
    Liu Q; Liu DW; Zheng MJ; Deng L; Wang HM; Jin S; Liu JJ; Hao YY; Zhu LC; Lin B
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
    PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.
    Wang S; Wang C; Hu Y; Li X; Jin S; Liu O; Gou R; Zhuang Y; Guo Q; Nie X; Zhu L; Liu J; Lin B
    J Exp Clin Cancer Res; 2020 Nov; 39(1):264. PubMed ID: 33246486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC3 positively regulates HE4 expression to promote ovarian carcinoma progression.
    Lou T; Zhuang H; Liu C; Zhang Z
    Arch Biochem Biophys; 2019 Oct; 675():108044. PubMed ID: 31302139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.
    Geethadevi A; Nair A; Parashar D; Ku Z; Xiong W; Deng H; Li Y; George J; McAllister DM; Sun Y; Kadamberi IP; Gupta P; Dwinell MB; Bradley WH; Rader JS; Rui H; Schwabe RF; Zhang N; Pradeep S; An Z; Chaluvally-Raghavan P
    Cancer Res; 2021 Oct; 81(20):5336-5352. PubMed ID: 34380633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between human epididymal protein 4 and depth of tumor invasion, postoperative recurrence, and metastasis of epithelial epithelial ovarian cancer.
    Li Y; Yu C; Li H; Feng Y; Fan P; Chen X
    Asia Pac J Clin Oncol; 2024 Aug; 20(4):472-480. PubMed ID: 38615275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
    Zhang T; Chu L; Tan W; Ye C; Dong H
    Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma.
    Mi D; Zhang Y
    Arch Gynecol Obstet; 2020 Mar; 301(3):779-785. PubMed ID: 32034508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HE4 (WFDC2) gene overexpression promotes ovarian tumor growth.
    Moore RG; Hill EK; Horan T; Yano N; Kim K; MacLaughlan S; Lambert-Messerlian G; Tseng YD; Padbury JF; Miller MC; Lange TS; Singh RK
    Sci Rep; 2014 Jan; 4():3574. PubMed ID: 24389815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer.
    Gao L; Zheng M; Guo Q; Nie X; Li X; Hao Y; Liu J; Zhu L; Lin B
    Int J Biochem Cell Biol; 2019 Nov; 116():105617. PubMed ID: 31550546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?
    El Bairi K; Afqir S; Amrani M
    Curr Drug Targets; 2020; 21(10):1026-1033. PubMed ID: 32334501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis.
    Li Y; Wang ZC; Luo L; Mu CY; Xu J; Feng Q; Li SB; Gu B; Ma P; Lan T
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):604-610. PubMed ID: 32016961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
    Roy R; Dagher A; Butterfield C; Moses MA
    Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.